Monday, December 10, 2007

Japanese Drugmaker Deals for MGI Pharma

Japanese Drugmaker Deals for MGI Pharma

Japanese drugmaker Eisai Co. said Monday it will buy U.S. biopharmaceutical company MGI Pharma Inc. for $3.9 billion in cash in a move aimed at boosting its cancer drug business and sustain sales growth.

ASSOCIATED PRESS

No comments:

Share |